IAS 2015 Conference Coverage

IAS 2015 Combo Treatments Promising for HIV-HCV Coinfection

Combo Treatments Promising for HIV-HCV Coinfection

Sustained virologic response for ledipasvir and sofosbuvir; and for daclatasvir and sofosbuvir.

IAS 2015 Strong Start Reported On PrEP For MSM, But More Adherence Support Urged

Strong Start Reported On PrEP For MSM, But More Adherence Support Urged

PrEP works when taken, results conclude.

IAS 2015 Teen's HIV Remains Under Control More Than A Decade After Stopping Tx

Teen's HIV Remains Under Control More Than A Decade After Stopping Tx

Girl is in remission of infection but she is still infected, not cured.

IAS 2015 Data On Early Initiation of ART Continue to Show Benefits

Data On Early Initiation of ART Continue to Show Benefits

Two studies show benefits in patients with asymptomatic HIV and in African patients.

Upcoming Meetings

Sign Up for Free e-newsletters